Ignite Creation Date:
2025-12-24 @ 3:42 PM
Ignite Modification Date:
2026-04-17 @ 2:09 PM
Study NCT ID:
NCT01486992
Status:
UNKNOWN
Last Update Posted:
2012-01-12
First Post:
2011-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-11
Completion Date Type:
ESTIMATED
First Submit Date:
2011-11-22
First Submit QC Date:
None
Study First Post Date:
2011-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-11
Last Update Post Date:
2012-01-12
Last Update Post Date Type:
ESTIMATED